Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004:10 Suppl 1:63-70.
doi: 10.1023/B:JICE.0000011347.53684.55.

Trials of pacing to control ventricular rate during atrial fibrillation

Affiliations
Review

Trials of pacing to control ventricular rate during atrial fibrillation

Mark A Wood. J Interv Card Electrophysiol. 2004.

Abstract

Pharmacologic therapy to achieve rate control in patients with atrial fibrillation is often difficult and inadequate. For this reason, ventricular pacing strategies have been developed as an alternative to drug therapy to alleviate symptoms due to rapid and irregular ventricular rates. Ventricular pacing in combination with AV junctional ablation provides palliative improvement in a wide range of clinical outcomes. Because of the irreversible complete AV block associated with this procedure, strategies to control the ventricular response to atrial fibrillation by ventricular pacing alone have been investigated. These strategies are primarily directed at regularizing the ventricular response by pacing at or near the mean intrinsically conducted ventricular rate. These specialized ventricular pacing algorithms provide striking ventricular regularity at rest but may be less effective during activity. No study has yet demonstrated clinically significant improvements in clinical outcomes with these algorithms. The clinical benefits of rate regularization alone without the strict rate control provided by AV junctional ablation are likely to be very limited. Other device based approaches to control ventricular rate in atrial fibrillation include transvenous vagal stimulation. This strategy is in early stages of development but may be promising.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Am Coll Cardiol. 1999 Dec;34(7):2043-50 - PubMed
    1. Am J Cardiol. 1998 Oct 16;82(8A):2N-9N - PubMed
    1. Am J Cardiol. 1998 Mar 1;81(5):594-8 - PubMed
    1. Can J Cardiol. 2001 Apr;17(4):437-45 - PubMed
    1. J Am Coll Cardiol. 1997 Oct;30(4):1039-45 - PubMed

LinkOut - more resources